Sinopharm
1099.HK
#1847
Rank
โ‚ฌ8.38 B
Marketcap
2,69ย โ‚ฌ
Share price
1.17%
Change (1 day)
20.90%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): โ‚ฌ2.29 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚ฌ80.05 Billion. In 2022 the company made an earning of โ‚ฌ3.08 Billion a decrease over its 2021 earnings that were of โ‚ฌ3.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚ฌ2.29 B-25.5%
2022 โ‚ฌ3.08 B-1.72%
2021โ‚ฌ3.13 B11.7%
2020โ‚ฌ2.80 B18.44%
2019โ‚ฌ2.36 B10.85%
2018โ‚ฌ2.13 B3.05%
2017โ‚ฌ2.07 B36.48%
2016โ‚ฌ1.51 B7.11%
2015โ‚ฌ1.41 B12.38%
2014โ‚ฌ1.26 B25.05%
2013โ‚ฌ1.00 B22.54%
2012โ‚ฌ0.82 B35.43%
2011โ‚ฌ0.60 B52.24%
2010โ‚ฌ0.39 B30.99%
2009โ‚ฌ0.30 B60.59%
2008โ‚ฌ0.18 B48.29%
2007โ‚ฌ0.12 B123.29%
2006โ‚ฌ57.36 M